RADNOR, PA – 2024年10月30日 – Certara, Inc. バイオシミュレーションのグローバルリーダーであるサターラ（Nasdaq：CERT) はCERT), a global leader in model-informed drug development, today announced the appointment of Dr. Tong Zhu, FCP, to lead its Clinical Pharmacology and Translational Medicine Group. Dr. Zhu will continue the group’s evolution of their mission to provide optimal clinical pharmacology strategy and quantitative, data-driven approaches to enhance decision-making throughout the drug development lifecycle.
“I am excited to welcome Tong to Certara as the head of our world-renowned Clinical Pharmacology and Translational Medicine Group,” said Fran Brown, PhD, Senior Vice President, Certara Drug Development Solutions. “Her long history in the pharmaceutical industry and expertise in early development, translational medicine, and clinical pharmacology make her the ideal choice to lead this group and continue our commitment to provide scientific rigor and customized development strategy for our industry partners.”
With nearly 25 years of experience specializing in translational medicine, early development, and clinical pharmacology, Dr. Zhu brings a wealth of knowledge in pharmaceutical research and development. Most recently she was responsible for leading Astellas’ Primary Focus strategy in Mitochondria Biology by working globally to help identify and develop innovative drugs targeting mitochondrial biology. アステラスではおよそ14年間、臨床薬理・探索開発部門でさまざまなリーダー職を歴任しました。アステラス入社以前は、アボット・グローバル・ファーマシューティカル・リサーチ・アンド・ディベロップメント（現アッヴィ）の臨床薬理およびファーマコメトリクスチームにて、様々なリーダーシップ職を歴任しました。
“Throughout my pharmaceutical career, I have known Certara as a trusted partner, providing software, solutions, and scientific leadership in drug development,” said Zhu. “I am excited to join Certara as the leader of the Clinical Pharmacology and Translational Medicine team and look forward to contributing to the mission of transforming drug development to accelerate the delivery of medicines that protect and enhance patient lives.”
サターラについて
サターラは、モデリング＆シミュレーション・ソフトウェアと技術を用いて、従来の創薬・開発を変革し、医薬品をよりスピーディーに患者さんに届けることをミッションとしています。製薬、教育機関、規制当局のお客様 2,400人以上、66ヵ国にてサターラの技術やサービスが活用されています。詳細は弊社ホームページをご覧ください。
お問合せ先
Sheila Rocchio
sheila.rocchio@certara.com
報道機関の皆様：
赤津笑美 (emi.akatsu@certara.com)
certara@pancomm.com
